This event is archived. Final snapshot from when the story concluded. View on Dashboard
Tech Medical study results

Cochrane Review Questions Intermittent Fasting Efficacy

Analysis based on 8 articles · First reported Feb 16, 2026 · Last updated Feb 18, 2026

Sentiment
0
Attention
2
Articles
8
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard

The findings from Cochrane's review could temper the enthusiasm for intermittent fasting, potentially shifting consumer spending away from related products and services. This may lead to a re-evaluation of dietary advice by healthcare providers and a focus on more traditional weight loss methods.

Healthcare Food and Beverage Pharmaceuticals

A new Cochrane review, led by Luis Garegnani and Eva Madrid, analyzed 22 clinical trials involving nearly 2,000 adults and found that intermittent fasting does not lead to significantly greater weight loss than traditional dietary advice or no intervention. The review challenges the widespread belief in the effectiveness of intermittent fasting, which has gained popularity through social media. Experts like Jörg Meerpohl and Stefan Kabisch noted the uncertainty of the evidence due to varied methods and short-term studies. The World Health Organization's data highlights the global obesity crisis, underscoring the importance of effective weight management strategies. The authors caution against extrapolating results to the entire population and recommend a case-by-case approach for doctors.

90 Cochrane published review on intermittent fasting effectiveness
80 Luis Garegnani led research and authored review Cochrane
70 Eva Madrid co-authored review and provided commentary Cochrane
ngo
Cochrane published a review challenging the effectiveness of intermittent fasting for weight loss, which could influence public health recommendations and dietary trends.
Importance 90 Sentiment 20
per
Luis Garegnani, as the lead author of the Cochrane review, is a key figure in presenting the findings that intermittent fasting does not offer significant weight loss advantages over traditional methods.
Importance 80 Sentiment 10
per
Eva Madrid, a senior author of the Cochrane review, emphasizes the difficulty of making general recommendations for weight loss due to the study's findings.
Importance 70 Sentiment 10
priv
The Hospital Italiano de Buenos Aires is associated with the lead author, Luis Garegnani, of the Cochrane review on intermittent fasting.
Importance 40 Sentiment 0
priv
The University of Valparaíso is associated with Eva Madrid, a senior author of the Cochrane review on intermittent fasting.
Importance 40 Sentiment 0
ngo
The World Health Organization's data on global obesity rates provides context for the importance of weight loss strategies, though it is not directly involved in the intermittent fasting study.
Importance 30 Sentiment 0
per
Jörg Meerpohl, director of Cochrane Germany, provides an external expert opinion on the study, noting the uncertainty of the results.
Importance 20 Sentiment 0
+ 5 more entities View on Dashboard
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.